Skip to content

IPHA

Innate Pharma SA

NASDAQ · Healthcare · Biotechnology · FR

$1.50
+0.00%
Ask drillr

Leverage

Debt / equity
-0.50x
Net debt / equity
-0.34x
Debt / assets
0.58x
Debt / EBITDA
-0.39x
Net debt / EBITDA
-0.26x

Liquidity & coverage

Current ratio
0.60x
Quick ratio
0.60x
Cash ratio
0.33x
Interest coverage
-16.39x
EBITDA / interest
-17.08x
Working capital
-$14.9M

Cash & dividend

FCF / debt
-2.22x
Cash flow / debt
-2.21x
Dividend per share
—
Dividend yield
—
Dividend growth 1y
—

Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026